Pliant Therapeutics Inc (FRA:9PT)
€ 10.9 -0.3 (-2.68%) Market Cap: 616.74 Mil Enterprise Value: 279.48 Mil PE Ratio: 0 PB Ratio: 1.87 GF Score: 38/100

Pliant Therapeutics Inc at Piper Sandler Healthcare Conference Transcript

Nov 30, 2022 / 03:30 PM GMT
Release Date Price: €18.5 (+0.54%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PLRX.OQ - Pliant Therapeutics Inc
Pliant Therapeutics Inc at Piper Sandler Healthcare Conference
Nov 30, 2022 / 03:30PM GMT

=====================
Conference Call Participants
=====================
* Yas Rahimi
Piper Sandler Companies - Analyst

=====================
Presentation
--------------------------------------------------------------------------------
Yas Rahimi, Piper Sandler Companies - Analyst [1]
--------------------------------------------------------------------------------
Thank you for joining our Piper Sandler Healthcare Conference here live in New York City. My name is Yas Rahimi. I am a senior biotech analyst here. Thrilled to be featuring the team from Pliant Therapeutics here.

Thank you for traveling from San Francisco to be here with us. That means a lot to us here all at Piper. We have lots to unpack over the next 25 minutes.

For my audience, I just encourage you if you have any question, just raise your hand and we'll pass the mic to you so you can ask questions.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot